A Single-Blind, Randomized Phase I/II Study of Pharmacokinetic and Pharmacodynamic Investigation of Modufolin (60 or 200 mg/m2) Compared to Levoleucovorin (60 or 200 mg/m2) in Tumor, Adjacent Mucosa and Plasma for Patients With Colon Cancer
Phase of Trial: Phase I/II
Latest Information Update: 25 May 2016
At a glance
- Drugs Arfolitixorin (Primary) ; Levofolinic acid
- Indications Colon cancer
- Focus Pharmacokinetics
- Sponsors Isofol Medical
- 04 Feb 2015 Results published in an Isofol Medical media release.
- 29 Aug 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 12 Mar 2013 Isofol has received interim results from the first 16 patients, according to a media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History